IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $555,978 | -4.2% | 12,257 | -13.3% | 0.00% | 0.0% |
| Q2 2023 | $580,246 | -36.7% | 14,142 | -44.9% | 0.00% | -50.0% |
| Q1 2023 | $916,802 | -9.2% | 25,652 | -4.0% | 0.00% | 0.0% |
| Q4 2022 | $1,009,403 | -29.9% | 26,725 | -17.9% | 0.00% | -33.3% |
| Q3 2022 | $1,440,000 | -28.3% | 32,564 | -40.0% | 0.00% | -25.0% |
| Q2 2022 | $2,008,000 | +7.2% | 54,230 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $1,874,000 | +25.8% | 50,585 | +3.3% | 0.00% | +33.3% |
| Q4 2021 | $1,490,000 | -3.7% | 48,981 | +6.1% | 0.00% | 0.0% |
| Q3 2021 | $1,548,000 | -13.4% | 46,156 | +3.0% | 0.00% | -25.0% |
| Q2 2021 | $1,788,000 | +12.0% | 44,831 | +26.2% | 0.00% | 0.0% |
| Q1 2021 | $1,597,000 | +53.9% | 35,529 | +93.5% | 0.00% | +33.3% |
| Q4 2020 | $1,038,000 | +48.9% | 18,362 | +25.0% | 0.00% | +50.0% |
| Q3 2020 | $697,000 | -28.5% | 14,691 | -11.1% | 0.00% | -33.3% |
| Q2 2020 | $975,000 | +28.1% | 16,530 | +2.7% | 0.00% | 0.0% |
| Q1 2020 | $761,000 | -5.6% | 16,089 | +20.7% | 0.00% | 0.0% |
| Q4 2019 | $806,000 | -20.8% | 13,335 | -21.5% | 0.00% | -25.0% |
| Q3 2019 | $1,018,000 | -21.1% | 16,992 | -15.4% | 0.00% | -20.0% |
| Q2 2019 | $1,291,000 | -7.3% | 20,080 | +17.0% | 0.01% | -16.7% |
| Q1 2019 | $1,393,000 | +164.8% | 17,157 | +76.4% | 0.01% | +100.0% |
| Q4 2018 | $526,000 | -3.7% | 9,724 | -8.2% | 0.00% | +50.0% |
| Q3 2018 | $546,000 | +25.2% | 10,595 | +1.2% | 0.00% | 0.0% |
| Q2 2018 | $436,000 | -47.0% | 10,473 | -43.8% | 0.00% | -60.0% |
| Q1 2018 | $822,000 | -6.7% | 18,649 | +6.5% | 0.01% | -16.7% |
| Q4 2017 | $881,000 | -15.5% | 17,518 | -14.8% | 0.01% | -14.3% |
| Q3 2017 | $1,043,000 | -4.5% | 20,565 | -4.2% | 0.01% | -12.5% |
| Q2 2017 | $1,092,000 | +35.5% | 21,475 | +7.1% | 0.01% | +33.3% |
| Q1 2017 | $806,000 | -17.4% | 20,054 | -1.7% | 0.01% | -25.0% |
| Q4 2016 | $976,000 | -9.5% | 20,411 | -30.6% | 0.01% | -20.0% |
| Q3 2016 | $1,078,000 | +60.7% | 29,410 | +2.1% | 0.01% | +66.7% |
| Q2 2016 | $671,000 | -34.1% | 28,800 | +14.6% | 0.01% | -50.0% |
| Q1 2016 | $1,018,000 | -31.0% | 25,129 | +5.5% | 0.01% | -29.4% |
| Q4 2015 | $1,475,000 | – | 23,821 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |